Cooper Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.96M Buy
2,911
+36
+1% +$21.4K 0.16% 108
2026
Q2
$1.44M Sell
2,875
-606
-17% -$291K 0.12% 129
2026
Q1
$1.71M Buy
3,481
+1,000
+40% +$543K 0.17% 104
2025
Q4
$1.44M Sell
2,481
-13
-0.5% -$7.35K 0.15% 107
2025
Q3
$1.21M Buy
2,494
+128
+5% +$59.6K 0.13% 126
2025
Q2
$959K Sell
2,366
-42
-2% -$17.6K 0.11% 147
2025
Q1
$1.2M Buy
2,408
+420
+21% +$227K 0.16% 119
2024
Q4
$1.03M Buy
1,988
+13
+0.7% +$7.15K 0.12% 141
2024
Q3
$1.22M Buy
1,975
+1,190
+152% +$704K 0.16% 111
2024
Q2
$434K Buy
785
+299
+62% +$171K 0.06% 240
2024
Q1
$282K Buy
486
+17
+4% +$9.54K 0.05% 298
2023
Q4
$249K Buy
+469
New +$227K 0.05% 298

Other funds holding TMO

Cooper Financial Group's TMO Position: Q3 2026 in Review

Cooper Financial Group increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q3 2026, buying an estimated $21.4K and bringing the position to 2,911 shares worth $1.96M. The position accounts for 0.16% of the portfolio, ranked #108.

Cooper Financial Group first reported a position in TMO in Q4 2023 and has held it in 12 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Cooper Financial Group held 2,911 shares of Thermo Fisher Scientific worth $1.96M as of Q3 2026.
  • Cooper Financial Group bought 36 Thermo Fisher Scientific shares in Q3 2026, an estimated $21.4K.
  • Thermo Fisher Scientific made up 0.16% of Cooper Financial Group's portfolio in Q3 2026, its #108 holding.
  • Cooper Financial Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 12 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Cooper Financial Group's 13F filing for Q3 2026, filed 7 Oct 2026.